Lemon Verbena

NutraPedia - Evidence-Based Supplement Research

Back to Table of Contents
Health Goals: digestion stress sleep

Research Overview

Overall, research on lemon verbena (Aloysia citrodora) has most heavily focused on (i) phytochemical characterization of its essential oil and extracts, and (ii) preclinical bioactivity testing. Across studies and reviews, the essential oil is commonly reported to be rich in the monoterpene aldehydes neral and geranial (citral isomers), while polar extracts are frequently characterized by high levels of phenylpropanoid glycosides, especially verbascoside. These chemical profiles underpin much of the experimental work assessing antioxidant capacity, antimicrobial effects, and other pharmacological activities in vitro and in animal models. A smaller but notable applied research area examines agronomic/physiological responses, including how foliar selenium or nano-selenium can mitigate salinity stress and increase photosynthetic performance and secondary metabolite accumulation in the plant.

The strongest evidence base supports antioxidant activity and antimicrobial/anti-biofilm mechanisms at the in vitro level, with several studies linking essential oil exposure to membrane disruption and leakage of cellular contents in bacteria. There is also consistent preclinical support for immunomodulatory/antioxidant effects in vivo in non-human systems (e.g., dietary leaf powder increasing lysozyme, immunoglobulins, cytokine gene expression, and antioxidant enzymes in rainbow trout). Antiproliferative/anticancer potential has been demonstrated in cell-based assays and supported by at least one mouse tumor model using an ethyl acetate extract, but these findings remain preliminary and mechanism-of-action attribution to specific constituents is not yet definitive.

Key gaps are in human evidence and translational rigor. The review literature emphasizes that safety, efficacy, dosing, and standardization are not yet adequately established in well-designed clinical trials, despite broad traditional use (e.g., for gastrointestinal complaints, insomnia/anxiety, and rheumatism). Additional needs include clearer identification of active principles (e.g., verbascoside vs. essential-oil constituents), pharmacokinetics and toxicology, reproducible extract/essential-oil standardization, and robust evaluation of interactions—both beneficial (e.g., synergy with antibiotics such as gentamicin) and adverse—under clinically relevant conditions.

1. What conditions has Lemon Verbena been studied for?

  • Oxidative stress / antioxidant defense: Studied in rats after acute intake of Lippia citriodora extract, measuring antioxidant enzymes in blood cells and myeloperoxidase (MPO) activity.

  • Inflammation-related vascular risk markers: In the same rat study, MPO (a marker linked to inflammatory vascular damage) was assessed and decreased after intake.

  • Overweight/obesity-related outcomes (in humans): A double-blind, placebo-controlled trial tested a supplement combining Lippia citriodora (LC) + Hibiscus sabdariffa (HS) polyphenols in 54 overweight subjects, measuring body weight, skinfolds/circumferences, blood pressure, hunger/satiety ratings, and quality of life (SF-36). (Abstract provided is truncated, so outcomes are not fully shown.)

  • Cancer/tumor growth (preclinical): Mouse tumor model (Balb/C mice) treated with an ethyl acetate extract showed reduced tumor size and some undetected tumors.

  • Antimicrobial/antibiofilm actions (in vitro):

    • Lemon verbena essential oil damaged bacterial cells and inhibited biomembrane (biofilm) formation in an isolate (“Pseudosciaena D4”).

    • Aqueous extract and the constituent verbascoside were tested with gentamicin against Staphylococcus aureus and Escherichia coli (standard resistant strains and clinical isolates) for synergy/potentiation.

  • Immune function and antioxidant enzymes (animal nutrition model): In rainbow trout, dietary lemon verbena leaf powder was studied for immune parameters (lysozyme, immunoglobulin, cytokine gene expression) and antioxidant enzymes (SOD, GST, GPx).

  • General traditional/ethnomedical indications (review): Diarrhea, flatulence, insomnia, rheumatism; also bronchitis, anxiety, digestive and heart problems—primarily as traditional uses, not necessarily supported by strong human clinical evidence in the abstracts.

2. Does it work in treating those conditions? Summarize the evidence.

  • Antioxidant and anti-inflammatory biomarker effects (animal evidence): After acute L. citriodora extract intake in rats, antioxidant enzymes (CAT, GPx, glutathione reductase) in lymphocytes/erythrocytes/neutrophils increased significantly (p<0.05) and neutrophil MPO activity decreased. Plasma contained verbascoside and isoverbascoside (reported ~80±10 and 57±4 ng/mL) plus multiple phenolic metabolites, supporting bioavailability and a plausible mechanism.

    Interpretation: Supports antioxidant-response modulation and reduced inflammatory MPO activity in an animal model, but does not prove clinical treatment of human disease.

  • Weight/overweight outcomes (human evidence, but incomplete in provided abstract): A double-blind placebo-controlled trial in 54 overweight subjects tested LC+HS polyphenol supplement and measured anthropometrics, blood pressure, appetite ratings, and SF-36. However, the abstract excerpt does not include results, so efficacy cannot be concluded from the provided text.

  • Anticancer/antiproliferative effects (preclinical): In mice inoculated with tumor cells, intraperitoneal ethyl acetate extract reduced tumor size by 57.97% and resulted in “undetected tumors” in 44.44% of treated mice. In vitro, extracts showed antioxidant activity (ethanol extract strongest in DPPH) and cytotoxicity in MTT assays.

    Interpretation: Promising preclinical signal, but not evidence of cancer treatment efficacy in humans; extract type, dosing, and safety need clarification.

  • Antimicrobial effects (mostly adjunctive or essential oil; in vitro):

    • Essential oil caused membrane damage/leakage and inhibited biofilm-related extracellular polysaccharide in a bacterial isolate, consistent with direct antimicrobial action in vitro.

    • Aqueous extract/verbascoside/caffeine alone showed no inhibition up to 200 µg/mL, but potentiated gentamicin against some resistant strains/clinical isolates; verbascoside + gentamicin showed synergistic activity (FICI<1) against clinical isolates in that study.

    Interpretation: Evidence supports potential as an antibiotic adjuvant (especially verbascoside) and essential-oil antimicrobial activity in vitro; not evidence for treating infections in humans.

  • Immune support (animal evidence in fish): In rainbow trout, 0.5–2% dietary leaf powder increased serum lysozyme and total immunoglobulin (P<0.05); 2% increased IL-8 and TNF-α expression; all doses increased IL-1β; antioxidant enzymes SOD increased at all doses and GST/GPx increased at 1–2%.

    Interpretation: Demonstrates immunomodulatory and antioxidant enzyme effects in fish; relevance to human immune outcomes is uncertain.

  • Traditional indications (human efficacy not established): The review notes many activities (antioxidant, anxiolytic, neuroprotective, sedative, antimicrobial, etc.) shown in cell/animal studies, but concludes safety and efficacy in humans are not fully assessed and that well-designed human studies are needed.

3. What health benefits does it have?

  • Antioxidant effects and bioactive polyphenols: Multiple abstracts emphasize antioxidant activity. Verbascoside is highlighted as a major extract component, and isolated glycosylated phenylpropanoids showed strong antioxidant capacity (while iridoids were weaker). In rats, intake increased endogenous antioxidant enzyme activities in blood cells.

  • Potential anti-inflammatory/vascular-protective signal: Rat study showed reduced neutrophil MPO activity after extract intake, which the authors link to potential anti-inflammatory and antiatherogenic activity (biomarker-level evidence).

  • Potential antimicrobial applications: Lemon verbena essential oil disrupted bacterial cell integrity and inhibited biofilm formation in vitro. Separately, verbascoside (and extract/caffeine) potentiated gentamicin against some resistant S. aureus and E. coli isolates in vitro (synergy reported for verbascoside + gentamicin in clinical isolates).

  • Preclinical anticancer potential: Ethyl acetate extract reduced tumor size in a mouse model and showed cytotoxic/antioxidant activity in lab assays; this is hypothesis-generating rather than proven clinical benefit.

  • Possible metabolic/weight-management relevance (uncertain from provided text): A human RCT exists for LC+HS polyphenols in overweight subjects, but the provided abstract segment does not report outcomes, so benefit cannot be confirmed here.

4. Does it have any downsides or side effects?

  • Human safety data is limited in the provided abstracts: The 2017 review explicitly notes lemon verbena is “not fully assessed regarding its safety and efficacy in human” and calls for well-designed human studies.

  • Essential oil potency may imply irritation/toxicity risk at inappropriate doses: The essential oil caused membrane disruption and cell death in bacteria in vitro. While this supports antimicrobial potential, it also underscores that concentrated essential oils can be biologically harsh; the abstracts provided do not report human tolerability, safe dosing, or adverse events.

  • Drug interaction potential (theoretical, based on synergy findings): Verbascoside/extract potentiated gentamicin activity in vitro. This does not prove a clinically meaningful interaction, but it suggests lemon verbena constituents could modify antimicrobial effects under some conditions. No clinical interaction studies are provided.

  • Quality/labeling and consumer-use risks (indirect): A survey of tea/herbal infusion consumers found many people do not read labels and some use products past expiry dates. This is not a lemon verbena-specific toxicity finding, but it highlights real-world misuse risks that could affect safety/quality of herbal infusions, including lemon verbena.

Overall, the abstracts provided do not document specific adverse effects in humans (e.g., rates of GI upset, sedation, liver enzyme changes). Absence of reported harms here should not be interpreted as proof of safety.

5. Is it beneficial or harmful for any genetic variations (pharmacogenomics)?

The provided abstracts do not evaluate pharmacogenomic effects (e.g., differences by CYP450 genotypes, transporter variants, inflammatory gene polymorphisms) for lemon verbena, verbascoside, or its metabolites. No genotype-stratified human outcomes, gene–supplement interactions, or variant-specific safety signals are reported.

Because the evidence here is limited to in vitro, animal studies, and a truncated human trial abstract (without genetic analyses), no evidence-based recommendations can be made regarding specific genetic variations.

References

  1. Exogenous application of selenium and nano-selenium alleviates salt stress and improves secondary metabolites in lemon verbena under salinity stress
    Fardin Ghanbari, Majid Bag-Nazari, Afsaneh Azizi (2023)
  2. Aloysia citrodora Paláu (Lemon verbena): A review of phytochemistry and pharmacology
    Roodabeh Bahramsoltani, Pourouchista Rostamiasrabadi, Zahra Shahpiri, André M Marques, Roja Rahimi (2018)
  3. Dietary supplementation of lemon verbena (Aloysia citrodora) improved immunity, immune-related genes expression and antioxidant enzymes in rainbow trout (Oncorrhyncus mykiss)
    Seyed Hossein Hoseinifar, Meysam Shakouri, Hien Van Doan, Shafigh Shafiei, Morteza Yousefi (2020)
  4. Antioxidant and Antiproliferation Activities of Lemon Verbena (Aloysia citrodora): An In Vitro and In Vivo Study
    Hasan M Rashid, Asma Ismail Mahmod, Fatma U Afifi, Wamidh H Talib (2022)
  5. Exploring tea and herbal infusions consumption patterns and behaviours: The case of Portuguese consumers
    Ana Catarina Sousa, Inês Pádua, Virgínia M F Gonçalves, Cláudia Ribeiro, Sandra Leal (2024)
  6. Antibacterial Activity and Antibacterial Mechanism of Lemon Verbena Essential Oil
    Xin Gao, Jinbao Liu, Bo Li, Jing Xie (2023)
  7. In vitroevaluation of antibacterial activity of verbascoside, lemon verbena extract and caffeine in combination with gentamicin against drug-resistantStaphylococcus aureusandEscherichia coliclinical isolates
    Bibi Sedigheh Fazly Bazzaz, Bahman Khameneh, Mohammad Reza Zahedian Ostad, Hossein Hosseinzadeh (2018)
  8. Relationships Between Chemical Structure and Antioxidant Activity of Isolated Phytocompounds from Lemon Verbena
    Noelia Sánchez-Marzo, Jesús Lozano-Sánchez, María de la Luz Cádiz-Gurrea, María Herranz-López, Vicente Micol (2019)
  9. Phenylpropanoids and their metabolites are the major compounds responsible for blood-cell protection against oxidative stress after administration of Lippia citriodora in rats
    R Quirantes-Piné, M Herranz-López, L Funes, I Borrás-Linares, V Micol (2013)
  10. Hibiscus and lemon verbena polyphenols modulate appetite-related biomarkers in overweight subjects: a randomized controlled trial
    Marina Boix-Castejón, María Herranz-López, Alberto Pérez Gago, Mariló Olivares-Vicente, Nuria Caturla (2018)
  11. Protective effect of aqueous and ethanolic extracts ofLippia citriodoraKunth.on acrylamide-induced neurotoxicity
    Zahra Tandisehpanah, Amir Foroutanfar, Ali Aziminia, Mahboobeh Ghasemzadeh Rahbardar, Bibi Marjan Razavi (2022)
  12. Lemon verbena (Lippia citriodora) polyphenols alleviate obesity-related disturbances in hypertrophic adipocytes through AMPK-dependent mechanisms
    María Herranz-López, Enrique Barrajón-Catalán, Antonio Segura-Carretero, Javier A Menéndez, Jorge Joven (2015)
  13. Contribution of Phenolics and Free Amino Acids on the Antioxidant Profile of Commercial Lemon Verbena Infusions
    Juliana A Barreto Peixoto, Gerardo Álvarez-Rivera, Anabela S G Costa, Susana Machado, Alejandro Cifuentes (2023)
  14. Verbascoside inhibits paraquate-induced pulmonary toxicity via modulating oxidative stress, inflammation, apoptosis and DNA damage in A549 cell
    Nastaran Khorashadizadeh, Ali Neamati, Mohammad Moshiri, Leila Etemad (2022)
  15. Effect of cold plasma on essential oil content and composition of lemon verbena
    Mohammad-Taghi Ebadi, Soleiman Abbasi, Amir Harouni, Fatemeh Sefidkon (2019)
  16. Effect of lemon verbena supplementation on muscular damage markers, proinflammatory cytokines release and neutrophils' oxidative stress in chronic exercise
    Lorena Funes, Lucrecia Carrera-Quintanar, Manuela Cerdán-Calero, Miguel D Ferrer, Franchek Drobnic (2011)
  17. Dietary Supplementation with an Extract ofAloysia citrodora(Lemon verbena) Improves Sleep Quality in Healthy Subjects: A Randomized Double-Blind Controlled Study
    Silvia Pérez-Piñero, Juan Carlos Muñoz-Carrillo, Jon Echepare-Taberna, Macarena Muñoz-Cámara, Cristina Herrera-Fernández (2024)
  18. Antioxidant effect of lemon verbena extracts in lymphocytes of university students performing aerobic training program
    L Carrera-Quintanar, L Funes, E Viudes, J Tur, V Micol (2012)
  19. Anxiolytic Effect and Improved Sleep Quality in Individuals TakingLippia citriodoraExtract
    Alejandro Martínez-Rodríguez, María Martínez-Olcina, Juan Mora, Pau Navarro, Nuria Caturla (2022)
  20. Effect of lemon verbena powder and vitamin C on performance and immunity of heat-stressed broilers
    F Rafiee, M Mazhari, M Ghoreishi, O Esmaeilipour (2016)


Want personalized supplement recommendations based on your genetics?
Upload Whole Genome Sequencing (WGS) raw DNA data today!
Or upload raw DNA data to get started with your free analysis!